Metabolomics by Dubey, Naveen Kumar
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
125,000 140M
TOP 1%154
5,000
1Chapter
Metabolomics
Naveen Kumar Dubey
Abstract
The aim of this chapter is to make a brief understanding on Metabolomics 
identification, extraction, and analysis techniques. As the name suggests, Metabolomics 
is the study of metabolites present in the body fluid (blood, plasma, urine, and saliva) 
or body parts (muscles, bone, tissue, and cells). These might be known metabolites or  
unknown metabolites. The metabolites can be endogenous (present in the body) 
or exogenous (formed by consuming external medicinal product). The molecular 
mass of these metabolites is usually lower (50–1500 Dalton) than the proteins and 
macromolecules. These metabolites can be extracted using various techniques such 
as solid phase extraction, liquid-liquid extraction, or simple protein precipitation. 
Extracted sample of metabolite then can be analyzed qualitatively or quantitatively 
using numerous analytical techniques such as high performance liquid chromatography 
(HPLC), liquid chromatography mass spectrometry (LC–MS/MS), dry blood spot 
(DBS), infrared (IR) spectroscopy, ultraviolet visible (UV) spectroscopy, nuclear 
magnetic resonance (NMR), ELISA, and chemiluminescence. Sensitivity of detection 
is the key factor, among many others, to decide which technique would be suitable for 
analysis. Liquid chromatography mass spectrometry (LC–MS/MS) is the latest and 
most sensitive technique among all the available methodology till date that has been 
extensively and exclusively used in current scenario.
Keywords: known metabolite, unknown metabolite, extraction, LC–MS/MS 
analysis, HPLC analysis, NMR analysis
1. Introduction
Current development, demand, and innovation in the field of science have made 
a tremendous effort to reduce the load of chemical/biologics in human body from 
gram to microgram level. Now scientists are evaluating how harmful is the effect 
of these chemicals (drugs) when consumed by any route in human body. Recent 
FDA/other regulatory agency examples are the presence of five to seven nitrosamine 
impurities (metabolites) (e.g., NDMA family) in sartan (e.g., valsartan, telmisartan, 
etc.) or ranitidine [1]. Lower therapeutic dose would be one of the solutions to 
reduce the level of these metabolites to an acceptable level in human matrix.
The metabolome is a close counterpart to the genome, the transcriptome, 
and the proteome. Together these four ‘omes’ constitute the building blocks of 
systems biology. Metabolomics is a newly emerging field of research concerned 
with the high-throughput identification and quantification of the small molecule 
metabolites in the metabolome. The metabolome can be defined as the complete 
complement of all small molecule (<1500 Da) metabolites found in a specific 
cell, organ, or organism. Metabolites are small molecules that are chemically 
transformed during metabolism and can provide a functional readout of the 
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cellular state. Metabolites, unlike genes and proteins, serve as direct signatures of 
biochemical activity and are much easier to correlate with phenotype. One of the 
challenges of systems biology and functional genomics is to integrate proteomic, 
transcriptomic, and metabolomic information to give a more complete picture 
of living organisms. While mRNA gene expression data and proteomic analyses 
do not tell the whole story of what might be happening in a cell, metabolic 
profiling can give an instantaneous snapshot of the physiology of that cell [2–6]. 
Pictorial diagram of all the omics interrelated to each other has been shown in 
Figures 1 and 2.
The metabolites formed in the body can be generated either by Phase 1 or Phase 2 
metabolic pathway [7]. The representation of these pathways is shown in Figure 3.
Regulatory guidance and agencies are emphasizing on the need of identification 
and analysis of each possible molecule separately and in combination with the 
intended matrix to generalize the pros and cons of that particular drug before 
human use [8–11].
Figure 2. 
Genes to phenotype.
Figure 1. 
The “omics” cascade.
3Metabolomics
DOI: http://dx.doi.org/10.5772/intechopen.92423
2. Metabolite extraction technique
When it comes to extract the metabolites from the bio-fluid (blood, plasma, 
serum, saliva, or urine), mainly three methodologies are prevailing. These are as 
follows.
2.1 Protein precipitation
This technique is very useful for high throughput as it involves only centrifuga-
tion step when a precipitating agent is added to matrix (plasma, blood, or serum). 
The basic principle for this technique is the amount or volume of precipitating 
agent must be sufficient to precipitate the protein present in the matrix. Selection of 
precipitating agent also depends on the technique involved for analysis of the com-
pound of interest. For example, trichloroacetic acid (TCA), perchloric acid (PCA), 
and zinc sulfate (ZnSO4) are not suitable for mass spectrometer (MS) analysis, 
whereas these are suitable for high performance liquid chromatography (HPLC) 
analysis [12]. Organic solvents such as methanol or acetonitrile are suitable for both 
HPLC and LC–MS/MS analysis [13–15]. The amount of precipitating agent varies 
for precipitating the matrix. TCA or PCA can be used directly (20–50 μL) in 500 μL 
of matrix [16–19]. Organic solvent should be 2–3 times the volume of matrix. After 
centrifugation, either sample can be directly injected into the HPLC or LC–MS/
MS or it can be concentrated in nitrogen evaporator followed by reconstitution. 
Centrifugation also plays an important role for this methodology [20]. Higher the 
revolution per minute (RPM) speed (~15,000 RPM) higher would be the sedimen-
tation of particle and cleaner would be the sample. Flow of protein precipitation is 
shown in Figure 4.
The drawback of this technique is high matrix effect, low recovery if the com-
pound of interest is associated with precipitated protein.
2.2 Liquid-Liquid extraction
The liquid-liquid extraction (LLE) technique [21–25] is one of the widely used 
methodologies to extract most of the metabolites from bio-matrix. The basic 
principle of this technique is portioning or separation of compound from one 
Figure 3. 
Metabolite pathways in human.
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liquid part to another one depending on its affinity. As we know, our body fluid 
(plasma … urine) is polar in nature; hence, less polar or nonpolar solvents such 
as ether/t-butyl methyl ether/ethyl acetate/dichloromethane are used to extract 
the compounds from the human matrix. The LLE technique can be used in many 
ways such as manual or automatic. Manual methodology would be cost effective 
when intelligent approach like freeze flash (using dry ice and methanol) is used 
along with vortexing the sample at high speed (2000–2500 RPM). Typical sample 
volume versus solvent volume is required in 1:3 ratio for proper extraction. Solvent 
needs to be evaporated in a nitrogen evaporator under constant temperature and 
pressure. The dried sample should be reconstituted in an appropriate solution for 
analysis on either HPLC or LC–MS/MS. Typical flow of the process is shown in 
Figure 5.
2.3 Solid-phase extraction
The cleanest process in extraction methodology is solid-phase extraction (SPE). 
This process involves the adsorption of compound on the solid surface (bed) of a 
polymeric membrane with a covalent and ionic interaction. Desorption of mol-
ecule takes place when a strong solvent/solution is passed through the surface of 
cartridge. Umpteen of SPE cartridge is available in the market staring from C18 to 
ionic (cation or anion) with weak and strong combination [26–28]. The cartridge 
can be of different platform like well plate of tube type. The polymeric membrane 
may vary from few milligram to few gram depending on the requirement of 
analysis. Matrix as low as 50 μL to as high as 3 mL can be employed for extraction 
using different format of SPE platform. Different kinds of protocols are used to 
Figure 4. 
Protein precipitation process.
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clean up the sample from matrix, which depend on the various trials conducted 
during development stage. SPE unit can be operated in both negative pressure 
mode (using vacuum manifold) and positive pressure mode (using nitrogen gas). 
Clean sample can be either directly injected into the HPLC or LC–MSMS system or 
concentrated to get high recovery. Pictorial presentation on SPE process is shown 
in Figure 6.
3. Dry blood spot technique
When there is a challenge of low sample volume (e.g., neonatal), it is advisable 
to look for innovation in this area. Dry blood spot (DBS) is a very useful technique 
that can support the low volume sample analysis. Just a spot is required on the 
polymeric membrane that can be cut in a circular shape using specific tools. The 
cut part then can be dissolved in a suitable solvent and directly injected on the high 
sensitive instrument for analysis [29–31]. The major challenge for this method is 
sensitivity achievement on the analytical instrument. Mass spectrometers (latest 
models) are the only way out for such kind of analysis (Figure 7).
Figure 5. 
Liquid liquid extraction methodology.
Figure 6. 
Solid phase extraction technique.
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4. Metabolite analysis technique
There are a variety of analytical techniques that could be employed for metabo-
lites identification and its analysis. Few of them are high performance liquid 
chromatography (HPLC), liquid chromatography mass spectrometry (LC–MSMS), 
nuclear magnetic resonance (NMR), ultraviolet visible spectrophotometer (UV), 
and infrared spectrophotometer (IR). Among all these, most reliable techniques are 
HPLC and LC–MSMS.
HPLC is a good technique for the analysis of formulation product in aqueous 
medium (nonhuman matrix) as there is no limitation of sample volume, 
concentration, and its detection. However, it would be a challenge when the analysis 
is to be done in human matrix due to obvious reason of low sample volume and 
hence its sensitivity on the instrument. Sensitivity on HPLC can be enhanced by 
replacing the UV detector by RF (fluorescence) detector provided the molecule if 
fluorescence is active. Derivatization methodology can also enhance the sensitivity 
of molecule by adding some auxochromes or chromophores to the main molecule 
moiety. Few examples are presented in Table 1, where parent molecules are not 
sensitive enough as such on HPLC analysis, however, using derivatizing reagent, 
sensitivity got enhanced.
Liquid chromatography when connected with mass spectrometer as detector, 
sensitivity of the molecule enhanced many folds by virtue of mass to charge (m/z) 
ratio detection. By enlarge, mass spectrometer is the only technique in the field of 
biomolecules and its analysis, by which one can quantitate the metabolites up to 
pg/ml level.
In the mass spectrometer, ion source plays a crucial role to ionize the molecule 
of interest. Basically, there are two kinds of ion sources predominantly used in 
S. No Molecule has low 
sensitivity (on HPLC)
Derivatizing agent Complex has high sensitivity  
(on HPLC)
1 Ethinyl estradiol Dansyl chloride Ethinyl estradiol-Dansyl complex
2 Valproic acid 2-bromo-2′-
acetonaphthone
Valproic-acid-2-bromo-2′-
acetonaphthone complex
3 Alendronate Diazomethane Alendronate-Diazomethane complex
4 Mesalamine Acetic anhydride Mesalamine-Acetic anhydride complex
Table 1. 
Molecule with derivatizing reagent.
Figure 7. 
Dry blood spot technique.
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entire pharma industry or academics. These are Electron spray ionization (ESI) and 
Atmospheric pressure chemical ionization (APCI).
4.1 Electro spray ionization (ESI)
The molecules of interest are first introduced into the ionization source of the 
mass spectrometer using an HPLC (or UPLC) system, where they are first ion-
ized to acquire positive or negative charges. The liquid associated with molecules 
get evaporated due to high temperature. Thereafter, due to coulombic repulsion 
between the ion, charged particles are formed. The ions then travel through the 
mass analyzer and arrive at different parts of the detector according to their mass/
charge (m/z) ratio. After the ions make contact with the detector, usable signals are 
generated and recorded by a computer system. The computer displays the signals 
graphically as a mass spectrum showing the relative abundance of the signals 
according to their m/z ratio. A typical pictorial diagram is shown in Figure 8.
4.2 Atmospheric pressure chemical ionization (APCI)
The APCI source is selected for molecules, which are thermally stable as the basic 
principle works on the fact of charge transfer from solvent molecule to the compound 
of interest in the ion source using corona discharge tube. The other operation in this 
ion source would remain same as ESI like transfer of ions from ion source to vacuum 
region and selective monitoring up to detector. APCI diagram is shown in Figure 9.
Figure 8. 
Electro spray ionisation mechanism.
Figure 9. 
Atmospheric pressure chemical ionisation mechanism.
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Both HPLC and LC-MS/MS techniques can be employed for identification and 
quantitation of metabolites in human matrix; however, both have some limitation 
and benefits. Table 2 represents the basic difference between both the techniques:
5. Conclusions
Metabolites are the compounds generated by our body after the consumption 
of drug substance. Some of these metabolites are known, and most of them are 
unknown. They may be harmful, beneficial, or inactive in the body. Extraction 
and detection are thus very important to understand complete behavior of these 
metabolites. Sensitive analytical technique like LC–MS/MS is the most employed 
methodology by most of the pharmaceutical/diagnostic companies as one can detect 
parent and all possible metabolites in one single run within 10- to 50-min time in 
human matrix.
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S. No Parameter HPLC LC–MS/MS
1 Run time High (5–100 min) Low (2–10 min)
2 Ratio of mobile 
phase
High aqueous (~70%) with low 
organic solvent (~30%)
Low aqueous (~30%) with high 
organic solvent (~70%)
3 Column 15–30 cm 5–15 cm
4 Efficiency Low High
5 Sensitivity Low High
6 Feasibility of 
analysis
Low High
7 Injection volume Low High
8 Matrix volume Low High
9 Cost Low High
Table 2. 
Comparison between HPLC and LC–MS/MS.
9Metabolomics
DOI: http://dx.doi.org/10.5772/intechopen.92423
Author details
Naveen Kumar Dubey
Indira Gandhi National Open University, New Delhi, India
*Address all correspondence to: nd005@rediffmail.com
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
10
Herbs and Spices
[1] FDA Updates and Press 
Announcements on Angiotensin 
II Receptor Blocker (ARB) Recalls 
(Valsartan, Losartan, and Irbesartan). 
Available from: https://www.fda.gov/
drugs/drug-safety-and-availability/
fda-updates-and-press-announcements-
angiotensin-ii-receptor-blocker-arb-
recalls-valsartan-losartan
[2] Oliver SG, Winson MK, Kell DB, 
Baganz F. Systematic functional 
analysis of the yeast genome. Trends in 
Biotechnology. 1998;16:373-378
[3] Yadav SP. The wholeness in suffix - 
omics, -omes, and the word om. 
Journal of Biomolecular Techniques. 
2007;18:277
[4] Wanjek C. Systems biology as 
defined by NIH. NIH Catalyst. Available 
from: https://irp.nih.gov/catalyst/v19i6/
systems-biology-as-defined-by-nih
[5] Dettmer K, Aronov PA, 
Hammock BD. Mass spectrometry-
based metabolomics. Mass 
Spectrometry Reviews. 2007;26:51-78
[6] Patti GJ, Yanes O, Siuzdak G. 
Innovation: Metabolomics: The apogee 
of the omics trilogy. Nature Reviews. 
Molecular Cell Biology. 2012;13:263-269
[7] Phase-I vs. Phase II Metabolism. 
Available from: https://step1.
medbullets.com/pharmacology/107006/
phase-i-vs-phase-ii-metabolism
[8] Bioanalytical Method Validation 
Guidance for Industry. 2018. Available 
from: https://www.fda.gov/downloads/
drugs/guidances/ucm070107.pdf
[9] Dubey NK, Fozdar BI. 
Interconversion from N-Desmethyl 
clomipramine to clomipramine 
and its impact on a bioequivalence 
study. Separation Science Plus. 
2018;1:714-725
[10] Guideline on Bioanalytical Method 
Validation [Online]. 2012. Available 
from: http://www.ema.europa.eu/docs/
en_GB/document_library/Scientific_
guideline/2011/08/WC500109686.pdf
[11] Overcoming the Charged Ion 
Competition in Triple Quad Chemical 
Ionization Ion Source for Estimation of 
Celecoxib in Biological Matrix and its 
Application to Bioequivalence Study. 
Drug Res/2019-03-1789/7.8.2019/MPS
[12] Di L, Kerns EH. Profiling drug-
like properties in discovery research. 
Current Opinion in Chemical Biology. 
2003;7(3):402-408
[13] White RE. High-throughput 
screening in drug metabolism 
and pharmacokinetic support in  
drug discovery. Annual Review 
of Pharmacology and Toxicology. 
2000;40:133-157
[14] Ulrich R, Friend SH. 
Toxicogenomics and drug discovery: 
Will new technologies help us  produce 
better drugs? Nature reviews. Drug 
Discovery. 2002;1:84-88
[15] Tarbit MH, Berman J. High-
throughput approaches for evaluating 
absorption, distribution, metabolism 
and excretion properties of lead 
compounds. Current Opinion in 
Chemical Biology. 1998;2(3):411-416
[16] Masimirembwa CM, Thompson R, 
Andersson TB. Handbook of 
pharmaceutical analysis. Combinatorial 
Chemistry & High Throughput 
Screening. 2001;4(3):245-263
[17] Dean JH, Olson HM. The integration 
of investigative toxicology in  the  drug 
discovery process. Biology of the Cell. 
1993;77(1):3-8
[18] Atterwill CK, Wing MG. In 
vitro preclinical lead optimisation  
References
11
Metabolomics
DOI: http://dx.doi.org/10.5772/intechopen.92423
technologies (PLOTs) in pharmaceutical 
development. Toxicology Letters. 
2002;127(1-3):143-151
[19] Amidon GL, Lennernas H, Shah VP, 
Crison JR. A theoretical basis for a 
biopharmaceutic drug classification: 
the correlation of in vitro drug product 
dissolution and in vivo bioavailability. 
Pharmaceutical Research. 
1995;12(3):413-420
[20] Meugge I. Selection criteria for 
drug-like compounds. Medicinal 
Research Reviews. 2003;23(3):302-321
[21] Fardy JJ, Ishimori T, Navratil JD, 
Sato T, Schulz WW. Solvent 
extraction applied to nuclear 
science. Atomic Energy Review. 
Available from: https://inis.iaea.org/
collection/NCLCollectionStore/_
Public/14/777/14777334.pdf
[22] Rice NM. Recommended 
nomenclature for solvent 
extraction. Chemistry & Industry. 
1977;3(6):718-723
[23] Misek T, editor. Recommended 
Systems for Liquid Extraction Studies. 
London: Institute of Chemical 
Engineers; 1978
[24] Roddy JW, McDowell WJ. 
Separation Systems Data Base: A Users’ 
Manual, Revision 1. Oak Ridge National 
Laboratory operated by Union Carbide 
Corporation for the USA department of 
Energy. ORNL/TM-6593/R1. 1978
[25] Wisniak J, Tamir A. Liquid–
Liquid Equilibrium and Extraction. 
Amsterdam: Elsevier; 1980
[26] Kinsella B, O’Mahony J, Malone E, 
et al. Current trends in sample 
preparation for growth promoter 
and veterinary drug residue analysis. 
Journal of Chromatography A. 
2009;1216(46):7977-8015
[27] Wen Y, Zhang M, Zhao Q , Feng 
Y-Q . Monitoring of five sulfonamide 
antibacterial residues in milk by 
in-tube solid-phase microextraction 
coupled to high-performance 
liquid chromatography. Journal of 
Agricultural and Food Chemistry. 
2005;53(22):8468-8473
[28] Barlow J. Antimicrobial resistance 
and the use of antibiotics in the dairy 
industry: Facing consumer perceptions 
and producer realities. Advances in 
Dairy Technology;23:47-58
[29] World Health Organization. 
Cardiovascular Diseases (CVDs). 2017. 
Available from: http://www.who.int/
mediacentre/factsheets/fs317/en/
[30] Lawes CM, Hoorn SV, Rodgers A. 
Global burden of blood-pressure-
related disease, 2001. The Lancet. 
2008;371(9623):1513-1518
[31] Campbell DJ, Mcgrady M, Prior DL, 
et al. Most individuals with treated 
blood pressures above target receive 
only one or two antihypertensive drug 
classes. Internal Medicine Journal. 
2013;43(2):137-143
